Literature DB >> 1663076

Tumour necrosis factor receptor distribution in human lymphoid tissue.

B Ryffel1, M Brockhaus, B Greiner, M J Mihatsch, F Gudat.   

Abstract

The nature and location of cells responding to tumour necrosis factor-alpha (TNF-alpha) were investigated in situ by immunohistochemistry using monoclonal antibodies (mAb) directed against the p75 and p55 proteins of the TNF receptor. Receptor expression was found in the thymus and secondary lymphoid tissues. In the thymus the p75 receptor was confined to medullary lymphoblasts and dendritic cells, which co-stain with the Tac protein of the interleukin-2 (IL-2) receptor. In lymph nodes and other secondary lymphoid tissues, the p75 receptor was expressed on activated lymphocytes and interdigitating reticulum cells of the T-cell area, whereas the p55 receptor was confined to the germinal centre dendritic reticulum cells (DRC), which is the main site of TNF-alpha production. TNF receptor (TNFR) proteins were up-regulated in reactive hyperplasia together with increased TNF-alpha expression. Surprisingly, no TNFR was detectable on non-lymphoid tissues. The species specificity of these TNFR antibodies was high: whereas the antibodies cross-reacted with epitopes in non-human primates, no immunoreactivity was detected in lower animal species, e.g. dog, rabbit and rodents. The data presented suggest that TNF-alpha, which is produced by germinal centre DRC, might regulate an in vivo immune response through autocrine and paracrine pathways, e.g. through the p55 and p75 receptor proteins, which are expressed at different sites of the lymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663076      PMCID: PMC1384638     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand.

Authors:  K Imamura; D Spriggs; D Kufe
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

Review 2.  Tumor necrosis factor and immunopathology.

Authors:  P F Piguet; G E Grau; P Vassalli
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers.

Authors:  A H Stolpen; E C Guinan; W Fiers; J S Pober
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

4.  Monokine production by hypersensitivity (Schistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages. Evidence for sequential production of IL-1 and tumor necrosis factor.

Authors:  S W Chensue; I G Otterness; G I Higashi; C S Forsch; S L Kunkel
Journal:  J Immunol       Date:  1989-02-15       Impact factor: 5.422

5.  Human lymphotoxin obtained from established lymphoid lines: purification characteristics and inhibition by anti-immunoglobulin.

Authors:  N Amino; E S Linn; T J Pysher; R Mier; G E Moore; L J DeGroot
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

6.  In vivo immunohistochemical identification of tumor necrosis factor/cachectin in human lymphoid tissue.

Authors:  J L McCall; K Yun; S Funamoto; B R Parry
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

7.  Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.

Authors:  P Scheurich; B Thoma; U Ucer; K Pfizenmaier
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

8.  Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences.

Authors:  Z Dembic; H Loetscher; U Gubler; Y C Pan; H W Lahm; R Gentz; M Brockhaus; W Lesslauer
Journal:  Cytokine       Date:  1990-07       Impact factor: 3.861

9.  Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.

Authors:  S S Sung; J M Bjorndahl; C Y Wang; H T Kao; S M Fu
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Effect of tumor necrosis factor alpha on mitogen-activated human B cells.

Authors:  J H Kehrl; A Miller; A S Fauci
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

View more
  14 in total

1.  Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term culture.

Authors:  A Larregina; A Morelli; E Kolkowski; L Fainboim
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells.

Authors:  B Wang; S Kondo; G M Shivji; H Fujisawa; T W Mak; D N Sauder
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

3.  Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration.

Authors:  M Cumberbatch; R J Dearman; I Kimber
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

4.  Role of tumour necrosis factor-alpha in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity.

Authors:  A M Moodycliffe; I Kimber; M Norval
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

5.  Thymocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(+) CD8(-) CD3(+) thymocytes: a critical role for tumor necrosis factor and interleukin-7.

Authors:  L Chêne; M T Nugeyre; E Guillemard; N Moulian; F Barré-Sinoussi; N Israël
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy.

Authors:  Ismail Sari; Omer Binicier; Merih Birlik; Servet Akar; Erkan Yilmaz; Aydanur Kargi; Fatos Onen; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2008-09-23       Impact factor: 2.631

7.  Is the follicular dendritic cell a primarily stationary cell?

Authors:  N Imazeki; A Senoo; Y Fuse
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

8.  Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor.

Authors:  M Kristensen; C Q Chu; D J Eedy; M Feldmann; F M Brennan; S M Breathnach
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

9.  Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization.

Authors:  M Cumberbatch; I Kimber
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

10.  Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-alpha.

Authors:  M Cumberbatch; I Fielding; I Kimber
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.